Target intelligence / Profile preview

Anterior nucleus of the thalamus (ANT)

Target
ANT
Molecular classification
Other (Anatomical brain region)
01

Overview

The anterior nucleus of the thalamus (ANT) is a critical component of the limbic system, specifically acting as a major relay station within the Circuit of Papez [StatPearls: Thalamus, 2023]. It receives significant input from the mammillary bodies via the mammillothalamic tract and projects primarily to the cingulate gyrus [Wikipedia: Anterior nuclei of thalamus]. Biologically, the ANT is essential for memory processing, spatial navigation, and the regulation of alertness. In clinical practice, the ANT has gained prominence as a primary therapeutic target for Deep Brain Stimulation (DBS) in patients with drug-resistant focal epilepsy [Fisher et al., Epilepsia, 2010]. By modulating the excitability of the limbic circuit, electrical stimulation of the ANT can significantly reduce seizure frequency [Salanova et al., Neurology, 2015]. While not a molecular target for traditional pharmacotherapy, its role in neurological disorders makes it a focal point for surgical and neuromodulatory interventions.

Other names
Anterior thalamic nucleiATNNucleus anterior thalamiAnterior thalamic nucleus group
02

Mechanism of action

Neuromodulation via high-frequency electrical stimulation (Deep Brain Stimulation) to disrupt abnormal synchrony in the Circuit of Papez, thereby increasing the seizure threshold [Fisher et al., Epilepsia, 2010].

03

Biological functions

Memory processing [StatPearls: Thalamus, 2023]Spatial navigation [Wikipedia: Anterior nuclei of thalamus]Limbic system integration [StatPearls: Thalamus, 2023]Alertness regulation [Wikipedia: Anterior nuclei of thalamus]Sensory relay [StatPearls: Thalamus, 2023]
04

Disease associations

Epilepsy [Fisher et al., Epilepsia, 2010]Alzheimer's disease [StatPearls: Thalamus, 2023]Amnesia [Wikipedia: Anterior nuclei of thalamus]Schizophrenia [Wikipedia: Anterior nuclei of thalamus]Dementia [StatPearls: Thalamus, 2023]
05

Safety considerations

Intracranial hemorrhage [Fisher et al., Epilepsia, 2010]Infection [Fisher et al., Epilepsia, 2010]Depression [Salanova et al., Neurology, 2015]Memory impairment [StatPearls: Thalamus, 2023]Sleep disturbances [Fisher et al., Epilepsia, 2010]
06

Biomarkers

Seizure frequency [Fisher et al., Epilepsia, 2010]Local field potentials [Salanova et al., Neurology, 2015]Fluorodeoxyglucose (FDG)-PET metabolism [Wikipedia: Anterior nuclei of thalamus]MRI volumetry [StatPearls: Thalamus, 2023]

Beyond the preview

Go deeper on Anterior nucleus of the thalamus (ANT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anterior nucleus of the thalamus (ANT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call